Internal Medicine, Infectious Disease · Petoskey, MI
NPI
1245226323
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
560 W Mitchell St, Suite 170
Petoskey, MI, 49770
Phone (231) 487-3590
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
496 services
Medicare patients, 2024
152
Average age 73
Drug cost, 2024
$552K
703 prescriptions
Company payments, 2024
$18.82
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen Denbesten was code 99232 (hospital e&m - subsequent), 214 times for 108 patients. In total Karen Denbesten billed 496 services in 7 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 214 | 108 | $64.20 | $14K |
| 99222 Hospital E&M - Initial | Facility | 133 | 119 | $106.93 | $14K |
By year: 2022 $40K for 570 services; 2023 $31K for 385 services; 2024 $41K for 496 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen Denbesten prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 84 prescriptions and refills. In total Karen Denbesten wrote 703 Medicare prescriptions that cost $552K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 84 | 84 | 23 | $9,047 |
| Daptomycin Generic | 75 | 75 | 16 | $17K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 75 | 75 | 21 | $20K |
| Cefazolin Sodium Generic | 51 | 51 | 14 | $3,584 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 43 | 43 | Under 11 | $172K |
| Cefepime Hcl Generic | 36 | 36 | Under 11 | $9,260 |
| Doxycycline Hyclate Generic | 31 | 33 | Under 11 | $286 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 30 | 64 | Under 11 | $370 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 29 | 29 | Under 11 | $124K |
| Vancomycin Hcl Generic | 24 | 24 | Under 11 | $2,206 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 21 | 23 | 11 | $780 |
| Meropenem Generic | 19 | 19 | Under 11 | $6,302 |
| Ertapenem Ertapenem Sodium | 18 | 18 | Under 11 | $7,517 |
| Levofloxacin Generic | 17 | 17 | Under 11 | $178 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 12 | 12 | Under 11 | $42K |
Brand drugs: - claims; generic drugs: 571 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Karen Denbesten $18.82 ($18.82 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $18.82.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $18.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.